<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="issn">2168-8184</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus</publisher-name><publisher-loc>Palo Alto (CA)</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013203</article-id><article-id pub-id-type="pmc">PMC11859851</article-id><article-id pub-id-type="doi">10.7759/cureus.78020</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pathology</subject></subj-group><subj-group><subject>Dermatology</subject></subj-group><subj-group><subject>Oncology</subject></subj-group></article-categories><title-group><article-title>Three Synchronous Non-melanoma Skin Cancers of the Head and Neck: A Case Report and Literature Review</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Muacevic</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Adler</surname><given-names>John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Keshk</surname><given-names>Eman</given-names></name><xref rid="aff-1" ref-type="aff">1</xref><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Moussa</surname><given-names>Adnene</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Kashif</surname><given-names>Ammara</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Alsulaiman</surname><given-names>Abdullah</given-names></name><xref rid="aff-3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Alafghani</surname><given-names>Saud</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Abdullah</surname><given-names>Nawal A</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Alqurashi</surname><given-names>Eyad S</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib></contrib-group><aff id="aff-1">
<label>1</label>
Histopathology Department, Ahmed Maher Teaching Hospital, Cairo, EGY </aff><aff id="aff-2">
<label>2</label>
Histopathology Unit, Laboratory Department, Al Hada Armed Forces Hospital, Taif, SAU </aff><aff id="aff-3">
<label>3</label>
Laboratory Department, Al Hada Armed Forces Hospital, Taif, SAU </aff><author-notes><corresp id="cor1">
Eman Keshk <email>dr.emanmostafa@gmail.com</email>
</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>1</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>1</month><year>2025</year></pub-date><volume>17</volume><issue>1</issue><elocation-id>e78020</elocation-id><history><date date-type="accepted"><day>26</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025, Keshk et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Keshk et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="https://www.cureus.com/articles/328413-three-synchronous-non-melanoma-skin-cancers-of-the-head-and-neck-a-case-report-and-literature-review">This article is available from https://www.cureus.com/articles/328413-three-synchronous-non-melanoma-skin-cancers-of-the-head-and-neck-a-case-report-and-literature-review</self-uri><abstract><p>Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common non-melanoma skin cancers, with exposure to ultraviolet (UV) light being the most important risk factor. These tumors usually affect older individuals with fair complexions. The co-occurrence of two or more non-melanoma skin cancers is a rare clinical event, the diagnosis of which rests on pathologic examination of the excised tumors. In this study, we report a case of the concurrent occurrence of three non-melanoma skin cancers on the head of a 90-year-old male patient with a history of long-term exposure to UV.</p></abstract><kwd-group kwd-group-type="author"><kwd>basal cell carcinoma</kwd><kwd>case report</kwd><kwd>histopathology</kwd><kwd>immunohistochemistry</kwd><kwd>squamous cell carcinoma</kwd><kwd>three tumors</kwd><kwd>ultraviolet light</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Squamous cell carcinoma (SCC) and basal cell carcinoma&#x000a0;(BCC) are the most common non-melanoma skin cancers (NMSCs) of the head and neck [<xref rid="REF1" ref-type="bibr">1</xref>]. Both typically occur in chronically sun-damaged skin of elderly people with fair skin tone [<xref rid="REF2" ref-type="bibr">2</xref>]. Other risk factors include genetic syndromes (albinism, xeroderma pigmentosum, and nevoid BCC syndrome) and immunosuppression [<xref rid="REF3" ref-type="bibr">3</xref>,<xref rid="REF4" ref-type="bibr">4</xref>]. The synchronous presence of two different types of skin cancer is a rare event and usually occurs as collision tumors [<xref rid="REF5" ref-type="bibr">5</xref>].</p><p>SCC is the second most common NMSC, with its incidence rising constantly in the past few years [<xref rid="REF6" ref-type="bibr">6</xref>]. This increase is attributed to previously mentioned risk factors in addition to the strong relationship with previous skin burns and human papillomavirus (HPV) infection [<xref rid="REF7" ref-type="bibr">7</xref>]; also, tumors can arise on top of predisposing dermatological conditions such as actinic keratosis, chronic wounds (Marjolin ulcer), porokeratosis, lichen sclerosus et atrophicus, hypertrophic or oral lichen planus, and discoid cutaneous lupus erythematosus [<xref rid="REF8" ref-type="bibr">8</xref>].</p><p>SCC poses significant morbidity and mortality to patients, similar to melanoma and other aggressive malignancies, with lymph node&#x000a0;metastasis being the most common metastatic route [<xref rid="REF8" ref-type="bibr">8</xref>]. Early diagnosis and proper surgical and oncologic treatment are of paramount importance to improve the life expectancy of the patients [<xref rid="REF9" ref-type="bibr">9</xref>]. Clinically, SCC presents as a scaly, erythematous, or hyperpigmented papule or plaque. Some cases may show ulceration, fungating mass, or pain [<xref rid="REF8" ref-type="bibr">8</xref>].</p><p>Proper diagnosis requires pathological examination of a skin biopsy, with classic SCC showing nests of squamous epithelial cells arising from the epidermis and extending deep into the dermis. The neoplastic cells are generally large with abundant eosinophilic cytoplasm and large central vesicular nuclei with variably prominent nucleoli. Variable keratinization can be detected, with well-differentiated tumors showing keratin pearl&#x000a0;formation [<xref rid="REF10" ref-type="bibr">10</xref>,<xref rid="REF11" ref-type="bibr">11</xref>].</p><p>SCC is graded as well, moderately, and poorly differentiated, depending on how easily the pathologist can recognize the characteristics of squamous epithelium (intracellular bridges and keratinization), pleomorphism, and mitotic activity [<xref rid="REF10" ref-type="bibr">10</xref>,<xref rid="REF11" ref-type="bibr">11</xref>]. Variants of SCC include spindle cell, clear cell, desmoplastic, follicular, keratoacanthoma-like, acantholytic, pseudovascular, metaplastic, inflammatory, basaloid, pigmented, infiltrative, pseudohyperplastic verrucous carcinoma, and adenosquamous carcinoma [<xref rid="REF11" ref-type="bibr">11</xref>]. The differential diagnosis includes porokeratosis, actinic keratosis, seborrheic keratosis, BCC, melanoma, psoriasis, lichen planus, among others [<xref rid="REF12" ref-type="bibr">12</xref>,<xref rid="REF13" ref-type="bibr">13</xref>].</p><p>Classic treatment entails either Mohs micrographic surgery or simple excision with a 4-6 mm safety margin. The former is preferred in high-risk cases (lesions greater than 2 cm, high-risk histological features, recurrent lesions, and cosmetically sensitive locations such as the ears, lips, nose, and periocular regions), in addition to immunosuppression&#x000a0;[<xref rid="REF14" ref-type="bibr">14</xref>]. Prognostically, localized tumors generally have an excellent prognosis. Mortality rate for SCC is approximately 2% [<xref rid="REF15" ref-type="bibr">15</xref>,<xref rid="REF16" ref-type="bibr">16</xref>].</p><p>On the other hand, BCC is the most common NMSC [<xref rid="REF17" ref-type="bibr">17</xref>], with the same risk factors for development as SCC. The tumor is more common in White people, while Black people are rarely affected [<xref rid="REF18" ref-type="bibr">18</xref>].&#x000a0;Cutaneous development of BCC increases the risk of developing other skin cancers, including SCC and malignant melanoma [<xref rid="REF19" ref-type="bibr">19</xref>].</p><p>BCC is a locally aggressive tumor with a low disease-associated mortality rate, and metastases are being exceptionally rare [<xref rid="REF20" ref-type="bibr">20</xref>]. The tumor commonly presents clinically as a pearly pink or flesh-colored papule or nodule with arborizing and branching vessels. When ulceration occurs, it gives rise to the term rodent ulcer [<xref rid="REF21" ref-type="bibr">21</xref>].</p><p>Histologically, the tumor has a lot of variants, with common and less common ones. Common variants include nodular and nodulocystic, infiltrative, morpheaform, keratotic, micronodular, adenoid, pigmented, basosquamous, superficial, ulcerative, and fibroepitheliomatous. Less common variants include clear cell, pleomorphic, signet ring cell, granular, infundibulocystic, metaplastic, keloidal, BCC with matricial differentiation, basomelanotic, BCC with thickened basement membrane, BCC with neuroid type nuclear palisading, and BCC with differentiation towards adnexal structures [<xref rid="REF11" ref-type="bibr">11</xref>]. The nodular variant is the most common variant, presenting with circumscribed sheets and nodules of basaloid cells with epidermal attachment, peripheral palisading, stromal retraction, and possibly fibromyxoid change. There may be extensive cystic change. Pleomorphism is generally unremarkable [<xref rid="REF11" ref-type="bibr">11</xref>].</p><p>Immunohistochemistry shows that the tumor cells are positive for cytokeratin AE1/AE3 (CK AE1/AE3), antihuman epithelial antigen BerEP-4, P63, CAM 5.2, cluster of differentiation 10 (CD10), 34BE12, and B-cell leukemia/lymphoma 2 protein (BCL-2) [<xref rid="REF22" ref-type="bibr">22</xref>]. Histologic mimics of BCC include, dermatofibroma, trichoepithelioma, basaloid follicular hamartoma, SCC syringoma, microcystic adnexal carcinoma, Merkel cell carcinoma, among others. Differentiation relies on clinical features, thorough histological examination, and the application of appropriate ancillary immunohistochemical markers [<xref rid="REF23" ref-type="bibr">23</xref>]. Treatment options include simple excision, Mohs surgery, topical 5-fluorouracil, radiation therapy, curettage, and electrodessication [<xref rid="REF24" ref-type="bibr">24</xref>].</p></sec><sec sec-type="cases"><title>Case presentation</title><p>A 90-year-old man presented to Al Hada Armed Forces Hospital&#x000a0;with three skin tumors on his face. The first one was on the forehead, the second one on the nose, and the third one on the upper lip. The patient was a former military recruit with a long history of exposure to ultraviolet radiation. Grossly, the first tumor was excised by simple excision, with a skin ellipse and underlying subcutis. The skin showed a central irregular ulcer with a variegated base measuring 4 x 2.5 cm, 0.5 cm away from the nearest side margin. It was dissected in a cruciate manner. The second tumor was also removed by simple excision, with a skin ellipse and underlying subcutaneous tissue, and it showed an ulcerated elevated nodule measuring 3.5 x 2.5 x 1.5 cm, 0.2 cm away from the nearest margin. It was dissected in a cruciate manner. The same type of surgery was done for the third tumor, with a piece of skin showing a central pearly white nodule 0.7 x 0.7 cm, 0.2 cm away from the nearest margin, and it was similarly dissected in a cruciate manner.</p><p>Histologic examination of the first (forehead) mass showed infiltrative BCC. The tumor was formed of infiltrating strands and interconnecting trabeculae of basaloid cells with mild peripheral palisading and stromal retraction, infiltrating among fibrocollagenous stroma. Tumor cells were connected to and ulcerating the overlying epidermis as well as focally reaching the subcutaneous fat, while all surgical margins were free of malignancy (Figure <xref rid="FIG1" ref-type="fig">1</xref>).</p><fig position="anchor" fig-type="figure" id="FIG1"><label>Figure 1</label><caption><title>Forehead tumor (infiltrative BCC). (A): Low-power view showing the whole mount of the tumor, H&#x00026;E &#x000d7;40. (B, C) Intermediate magnification showing strands and trabeculae of intercommunicating tumor cells connected to the overlying epidermis, H&#x00026;E &#x000d7;100. (D) Higher magnification showing the basaloid nature of the tumor cells with mild pleomorphism. Note that peripheral palisading and stromal retraction are not marked in this subtype of BCC, H&#x00026;E &#x000d7;200.</title><p>BCC: basal cell carcinoma; H&#x00026;E:&#x000a0;hematoxylin and eosin.</p></caption><graphic xlink:href="cureus-0017-00000078020-i01" position="float"/></fig><p>Immunohistochemical studies showed that the tumor was positive for the epithelial adhesion molecule (BerEP4) and cluster of differentiation 10 (CD10) (Figure <xref rid="FIG2" ref-type="fig">2</xref>).</p><fig position="anchor" fig-type="figure" id="FIG2"><label>Figure 2</label><caption><title>Forehead tumor (infiltrative BCC). (A, B) IHC showing positive membranous staining of the tumor cells for BerEP4, &#x000d7;40 and &#x000d7;100, respectively. (C, D) IHC showing positive membranous and cytoplasmic staining of the tumor cells for CD10, &#x000d7;100.</title><p>BCC: basal cell carcinoma; IHC: immunohistochemistry.</p></caption><graphic xlink:href="cureus-0017-00000078020-i02" position="float"/></fig><p>Histologic examination of the second (nasal) mass showed nodular BCC, formed of circumscribed nodules and sheets of neoplastic basaloid cells, with peripheral palisading and stromal retraction, with areas of identifiable lymphovascular invasion and infiltration of the deep dermis (Clark level IV). All surgical margins were free of malignancy (Figure <xref rid="FIG3" ref-type="fig">3</xref>).</p><fig position="anchor" fig-type="figure" id="FIG3"><label>Figure 3</label><caption><title>Nasal tumor (nodular BCC). (A, B) H&#x00026;E showing circumscribed nodules of neoplastic basaloid cells, &#x000d7;40 and &#x000d7;100, respectively. (C) Tumor cells showing peripheral palisading and stromal retraction, H&#x00026;E &#x000d7;100. (D) Tumor nest was seen infiltrating blood vessel (lymphovascular invasion), H&#x00026;E &#x000d7;200.</title><p>BCC: basal cell carcinoma;&#x000a0;H&#x00026;E:&#x000a0;hematoxylin and eosin.</p></caption><graphic xlink:href="cureus-0017-00000078020-i03" position="float"/></fig><p>IHC showed that the tumor was positive for BerEP4&#x000a0;and CD10 (Figure <xref rid="FIG4" ref-type="fig">4</xref>).</p><fig position="anchor" fig-type="figure" id="FIG4"><label>Figure 4</label><caption><title>Nasal tumor (nodular BCC). (A, B) Positive membranous and cytoplasmic staining of the tumor cells for positive CD10. CD10 IHC, &#x000d7;100 and &#x000d7;200, respectively. (C, D) Tumor cell nodules showing positive staining for BerEp4. BerEP4 IHC, &#x000d7;40 and &#x000d7;100, respectively.</title><p>BCC: basal cell carcinoma; IHC:&#x000a0;immunohistochemistry.</p></caption><graphic xlink:href="cureus-0017-00000078020-i04" position="float"/></fig><p>Histological examination of the third (upper lip) tumor showed invasive well-differentiated SCC, in which the tumor forms sheets and nodules of neoplastic squamous cells with mild pleomorphism and evident keratin pearl formation. The tumor was seen infiltrating facial skeletal muscles with areas of perineural invasion. All surgical margins were free of malignancy (Figure <xref rid="FIG5" ref-type="fig">5</xref>).</p><fig position="anchor" fig-type="figure" id="FIG5"><label>Figure 5</label><caption><title>Upper lip tumor (well-differentiated SCC). (A, B) H&#x00026;E-stained sections of the tumor showed well-differentiated SCC, with abundant keratinization, &#x000d7;20 and &#x000d7;100, respectively. (C, D) Nests of neoplastic squamous cells were seen infiltrating skeletal muscle bundles, H&#x00026;E &#x000d7;40 and &#x000d7;100, respectively.</title><p>SCC:&#x000a0;squamous cell carcinoma; H&#x00026;E: hematoxylin and eosin.</p></caption><graphic xlink:href="cureus-0017-00000078020-i05" position="float"/></fig><p>Immunohistochemically, the tumor cells showed&#x000a0;positive nuclear staining for P63 and P40, while cytokeratin 5/6 (CK5/6) showed positive cytoplasmic staining&#x000a0;(Figure <xref rid="FIG6" ref-type="fig">6</xref>).</p><fig position="anchor" fig-type="figure" id="FIG6"><label>Figure 6</label><caption><title>Upper lip tumor (well-differentiated SCC). (A) P63 showing positive nuclear staining of the tumor. P63, &#x000d7;100. (B) P40 showing positive nuclear staining of the tumor cells. P40, &#x000d7;100. (C, D) CK5/6 showing positive cytoplasmic staining of the tumor cells. CK5/6, &#x000d7;40 and &#x000d7;100, respectively.</title><p>SCC: squamous cell carcinoma; CK5/6: cytokeratin 5/6.</p></caption><graphic xlink:href="cureus-0017-00000078020-i06" position="float"/></fig><p>This case was diagnosed in October 2024. Follow-up of the patient shows favorable outcome, good cosmetic results, and no evidence of lymph node or distant metastasis.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Co-occurrence of multiple malignant skin tumors has been rarely reported in the past [<xref rid="REF25" ref-type="bibr">25</xref>]. We reported a case of three synchronous NMSCs in the head and neck of a 90-year-old male patient, who was a previous military recruit: infiltrative BCC, nodular BCC, and SCC. Most studies have reported that the head and neck are the most common sites for these tumors, with the male gender more commonly affected than females [<xref rid="REF26" ref-type="bibr">26</xref>].</p><p>Our reported variants of BCC are among the most common variants of BCC [<xref rid="REF11" ref-type="bibr">11</xref>], while the SCC reported was a well-differentiated classic variant, which has been reported as the most common variant of SCC [<xref rid="REF11" ref-type="bibr">11</xref>]. In our case, both carcinomas were completely resected with safe margins and plastic reconstruction. The standard treatment for cutaneous BCC and SCC is either Mohs surgery or simple excision with a 4-6 mm safety margin [<xref rid="REF27" ref-type="bibr">27</xref>].</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In summary, this report documents a rare and unusual case of three synchronous NMSCs: infiltrative BCC, nodular BCC, and well-differentiated SCC, identified on the face of a 90-year-old male patient, who was a former military recruit. These tumors are more common in elderly male patients. Biopsies with histological assessment are the key to the correct diagnosis due to the variations in tumor morphology. A complete resection of all carcinomas with safe margins and plastic reconstruction was performed. Clinicians and pathologists need to be more cautious when working up such lesions.</p></sec></body><back><fn-group content-type="conflict"><title>Disclosures</title><fn fn-type="COI-statement"><p><bold>Human subjects:</bold> Consent for treatment and open access publication was obtained or waived by all participants in this study. Al Hada Military Hospital Ethics Committee issued approval H-02-T-078.</p><p><bold>Conflicts of interest:</bold> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p><p><bold>Payment/services info:</bold> All authors have declared that no financial support was received from any organization for the submitted work.</p><p><bold>Financial relationships:</bold> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p><p><bold>Other relationships:</bold> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p></fn></fn-group><fn-group content-type="other"><title>Author Contributions</title><fn fn-type="other"><p><bold>Concept and design:</bold>&#x000a0; Eman Keshk, Adnene Moussa, Ammara Kashif, Abdullah Alsulaiman, Nawal A. Abdullah, Saud Alafghani, Eyad S. Alqurashi</p><p><bold>Acquisition, analysis, or interpretation of data:</bold>&#x000a0; Eman Keshk, Adnene Moussa, Ammara Kashif, Abdullah Alsulaiman, Nawal A. Abdullah, Saud Alafghani</p><p><bold>Drafting of the manuscript:</bold>&#x000a0; Eman Keshk, Adnene Moussa, Ammara Kashif, Nawal A. Abdullah, Saud Alafghani, Eyad S. Alqurashi</p><p><bold>Critical review of the manuscript for important intellectual content:</bold>&#x000a0; Eman Keshk, Adnene Moussa, Ammara Kashif, Abdullah Alsulaiman, Nawal A. Abdullah</p><p><bold>Supervision:</bold>&#x000a0; Eman Keshk, Adnene Moussa, Ammara Kashif, Abdullah Alsulaiman, Saud Alafghani, Eyad S. Alqurashi</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="journal"><article-title>A case of dual squamous cell carcinoma of face successfully treated with surgery. IP</article-title><source>Indian J Clin Exp Dermatol</source><person-group>
<name><surname>Sharma</surname><given-names>N</given-names></name>
<name><surname>Pathania</surname><given-names>S</given-names></name>
<name><surname>Goel</surname><given-names>M</given-names></name>
<name><surname>Singh Dogra</surname><given-names>S</given-names></name>
</person-group><fpage>200</fpage><lpage>202</lpage><volume>6</volume><year>2020</year><uri xlink:href="https://www.ijced.org/article-details/11565">https://www.ijced.org/article-details/11565</uri></element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>Basal cell and squamous cell skin cancers</article-title><source>J Natl Compr Canc Netw</source><person-group>
<name><surname>Miller</surname><given-names>SJ</given-names></name>
<name><surname>Alam</surname><given-names>M</given-names></name>
<name><surname>Andersen</surname><given-names>J</given-names></name>
<etal/>
</person-group><fpage>836</fpage><lpage>864</lpage><volume>8</volume><year>2010</year><pub-id pub-id-type="pmid">20870631</pub-id>
</element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="book"><article-title>Skin cancer in the immunosuppressed host</article-title><source>Cutaneous Oncology: Pathophysiology, Diagnosis, and Management </source><person-group>
<name><surname>Cobb</surname><given-names>M</given-names></name>
</person-group><fpage>51</fpage><lpage>60</lpage><publisher-loc>Malden, MA</publisher-loc><publisher-name>Blackwell Science</publisher-name><year>1998</year><uri xlink:href="https://openlibrary.org/books/OL661843M/Cutaneous_oncology">https://openlibrary.org/books/OL661843M/Cutaneous_oncology</uri></element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="book"><article-title>Genetic syndromes predisposing to skin cancer development</article-title><source>Cutaneous Oncology: Pathophysiology, Diagnosis, and Management</source><person-group>
<name><surname>McGregor</surname><given-names>J</given-names></name>
<name><surname>Hawk</surname><given-names>J</given-names></name>
</person-group><fpage>158</fpage><lpage>168</lpage><publisher-loc>Malden, MA</publisher-loc><publisher-name>Blackwell Science</publisher-name><year>1998</year><uri xlink:href="https://openlibrary.org/books/OL661843M/Cutaneous_oncology">https://openlibrary.org/books/OL661843M/Cutaneous_oncology</uri></element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal"><article-title>Synchronous non-collision melanoma and basal cell carcinoma arising from chronic lymphedema: a case report and review of literature</article-title><source>J Surg Case Rep</source><person-group>
<name><surname>Jaafar</surname><given-names>S</given-names></name>
<name><surname>Jestila</surname><given-names>T</given-names></name>
<name><surname>Waheed</surname><given-names>A</given-names></name>
<name><surname>Misra</surname><given-names>S</given-names></name>
<name><surname>Thakkar</surname><given-names>D</given-names></name>
</person-group><fpage>0</fpage><volume>2019</volume><year>2019</year></element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging</article-title><source>J Am Acad Dermatol</source><person-group>
<name><surname>Que</surname><given-names>SK</given-names></name>
<name><surname>Zwald</surname><given-names>FO</given-names></name>
<name><surname>Schmults</surname><given-names>CD</given-names></name>
</person-group><fpage>237</fpage><lpage>247</lpage><volume>78</volume><year>2018</year><pub-id pub-id-type="pmid">29332704</pub-id>
</element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>Risk of skin cancer in patients with HIV: a Danish nationwide cohort study</article-title><source>J Am Acad Dermatol</source><person-group>
<name><surname>Omland</surname><given-names>SH</given-names></name>
<name><surname>Ahlstr&#x000f6;m</surname><given-names>MG</given-names></name>
<name><surname>Gerstoft</surname><given-names>J</given-names></name>
<etal/>
</person-group><fpage>689</fpage><lpage>695</lpage><volume>79</volume><year>2018</year><pub-id pub-id-type="pmid">29588249</pub-id>
</element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="book"><article-title>Cutaneous squamous cell carcinoma</article-title><source>StatPearls [Internet]</source><date-in-citation content-type="access-date">
<month>2</month>
<year>2025</year>
</date-in-citation><person-group>
<name><surname>Hadian</surname><given-names>Y</given-names></name>
<name><surname>Howell</surname><given-names>JY</given-names></name>
<name><surname>Ramsey</surname><given-names>ML</given-names></name>
<name><surname>Buckley</surname><given-names>C</given-names></name>
</person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK441939/">https://www.ncbi.nlm.nih.gov/books/NBK441939/</uri></element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal"><article-title>Cutaneous squamous cell carcinoma: management of advanced and high-stage tumors</article-title><source>J Am Acad Dermatol</source><person-group>
<name><surname>Que</surname><given-names>SK</given-names></name>
<name><surname>Zwald</surname><given-names>FO</given-names></name>
<name><surname>Schmults</surname><given-names>CD</given-names></name>
</person-group><fpage>249</fpage><lpage>261</lpage><volume>78</volume><year>2018</year><pub-id pub-id-type="pmid">29332705</pub-id>
</element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="book"><article-title>Tumors</article-title><source>Weedon&#x02019;s Skin Pathology</source><person-group>
<name><surname>Patterson</surname><given-names>JW</given-names></name>
</person-group><fpage>859</fpage><lpage>865</lpage><publisher-loc>London, UK</publisher-loc><publisher-name>Elsevier</publisher-name><year>2021</year><uri xlink:href="https://books.google.co.in/books?id=3_m-DwAAQBAJ&#x00026;pg=PA47&#x00026;source=gbs_toc_r&#x00026;cad=2#v=onepage&#x00026;q&#x00026;f=false">https://books.google.co.in/books?id=3_m-DwAAQBAJ&#x00026;pg=PA47&#x00026;source=gbs_toc_r&#x00026;cad=2#v=onepage&#x00026;q&#x00026;f=false</uri></element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="book"><article-title>Tumors of the surface epithelium</article-title><source>McKee's Pathology of the Skin, 5th Edition</source><person-group>
<name><surname>Calonje</surname><given-names>E</given-names></name>
<name><surname>Brenn</surname><given-names>T</given-names></name>
<name><surname>Lazar</surname><given-names>A</given-names></name>
<name><surname>McKee</surname><given-names>PH</given-names></name>
</person-group><fpage>1198</fpage><lpage>1208</lpage><publisher-loc>2019</publisher-loc><publisher-name>Elsevier/Saunders</publisher-name><year>2019</year><uri xlink:href="https://shop.elsevier.com/books/mckees-pathology-of-the-skin/calonje/978-0-7020-6983-3">https://shop.elsevier.com/books/mckees-pathology-of-the-skin/calonje/978-0-7020-6983-3</uri></element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="journal"><article-title>Voriconazole and the risk of keratinocyte carcinomas among lung transplant recipients in the United States</article-title><source>JAMA Dermatol</source><person-group>
<name><surname>D'Arcy</surname><given-names>ME</given-names></name>
<name><surname>Pfeiffer</surname><given-names>RM</given-names></name>
<name><surname>Rivera</surname><given-names>DR</given-names></name>
<etal/>
</person-group><fpage>772</fpage><lpage>779</lpage><volume>156</volume><year>2020</year><pub-id pub-id-type="pmid">32401271</pub-id>
</element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal"><article-title>Concomitant hypertrophic lichen planus and squamous cell carcinoma: clinical features and treatment outcomes</article-title><source>Int J Dermatol</source><person-group>
<name><surname>Idriss</surname><given-names>MH</given-names></name>
<name><surname>Barbosa</surname><given-names>N</given-names></name>
<name><surname>Chang</surname><given-names>MB</given-names></name>
<name><surname>Gibson</surname><given-names>L</given-names></name>
<name><surname>Baum</surname><given-names>CL</given-names></name>
<name><surname>Vidal</surname><given-names>NY</given-names></name>
</person-group><fpage>1527</fpage><lpage>1531</lpage><volume>61</volume><year>2022</year><pub-id pub-id-type="pmid">35766459</pub-id>
</element-citation></ref><ref id="REF14"><label>14</label><element-citation publication-type="journal"><article-title>AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery</article-title><source>J Am Acad Dermatol</source><person-group>
<name><surname>Connolly</surname><given-names>SM</given-names></name>
<name><surname>Baker</surname><given-names>DR</given-names></name>
<name><surname>Coldiron</surname><given-names>BM</given-names></name>
<etal/>
</person-group><fpage>531</fpage><lpage>550</lpage><volume>67</volume><year>2012</year><pub-id pub-id-type="pmid">22959232</pub-id>
</element-citation></ref><ref id="REF15"><label>15</label><element-citation publication-type="journal"><article-title>The risk of metastases from squamous cell carcinoma of the skin</article-title><source>Int J Dermatol</source><person-group>
<name><surname>Caudill</surname><given-names>J</given-names></name>
<name><surname>Thomas</surname><given-names>JE</given-names></name>
<name><surname>Burkhart</surname><given-names>CG</given-names></name>
</person-group><fpage>483</fpage><lpage>486</lpage><volume>62</volume><year>2023</year><pub-id pub-id-type="pmid">35324009</pub-id>
</element-citation></ref><ref id="REF16"><label>16</label><element-citation publication-type="journal"><article-title>All-cause mortality in patients with basal and squamous cell carcinoma: a systematic review and meta-analysis</article-title><source>J Am Acad Dermatol</source><person-group>
<name><surname>Wehner</surname><given-names>MR</given-names></name>
<name><surname>Cidre Serrano</surname><given-names>W</given-names></name>
<name><surname>Nosrati</surname><given-names>A</given-names></name>
<name><surname>Schoen</surname><given-names>PM</given-names></name>
<name><surname>Chren</surname><given-names>MM</given-names></name>
<name><surname>Boscardin</surname><given-names>J</given-names></name>
<name><surname>Linos</surname><given-names>E</given-names></name>
</person-group><fpage>663</fpage><lpage>672</lpage><volume>78</volume><year>2018</year><pub-id pub-id-type="pmid">29146125</pub-id>
</element-citation></ref><ref id="REF17"><label>17</label><element-citation publication-type="journal"><article-title>Multiple skin neoplasms at one site (MUSK IN A NEST): a comprehensive review of basal cell carcinoma and benign or malignant &#x0201c;collision&#x0201d; tumors at the same cutaneous location</article-title><source>Clin Cosmet Investig Dermatol</source><person-group>
<name><surname>Cohen</surname><given-names>PR</given-names></name>
<name><surname>Calame</surname><given-names>A</given-names></name>
</person-group><fpage>731</fpage><lpage>741</lpage><volume>13</volume><year>2020</year></element-citation></ref><ref id="REF18"><label>18</label><element-citation publication-type="journal"><article-title>Genetics and risk factors for basal cell carcinoma</article-title><source>Br J Dermatol</source><person-group>
<name><surname>Madan</surname><given-names>V</given-names></name>
<name><surname>Hoban</surname><given-names>P</given-names></name>
<name><surname>Strange</surname><given-names>RC</given-names></name>
<name><surname>Fryer</surname><given-names>AA</given-names></name>
<name><surname>Lear</surname><given-names>JT</given-names></name>
</person-group><fpage>5</fpage><lpage>7</lpage><volume>154 Suppl 1</volume><year>2006</year><pub-id pub-id-type="pmid">16712709</pub-id>
</element-citation></ref><ref id="REF19"><label>19</label><element-citation publication-type="journal"><article-title>Environment, phenotype and genetics: risk factors associated with BCC of the skin</article-title><source>Expert Rev Anticancer Ther</source><person-group>
<name><surname>Hoban</surname><given-names>PR</given-names></name>
<name><surname>Ramachandran</surname><given-names>S</given-names></name>
<name><surname>Strange</surname><given-names>RC</given-names></name>
</person-group><fpage>570</fpage><lpage>579</lpage><volume>2</volume><year>2002</year><pub-id pub-id-type="pmid">12382525</pub-id>
</element-citation></ref><ref id="REF20"><label>20</label><element-citation publication-type="journal"><article-title>Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management</article-title><source>Future Oncol</source><person-group>
<name><surname>Correia de S&#x000e1;</surname><given-names>TR</given-names></name>
<name><surname>Silva</surname><given-names>R</given-names></name>
<name><surname>Lopes</surname><given-names>JM</given-names></name>
</person-group><fpage>3023</fpage><lpage>3038</lpage><volume>11</volume><year>2015</year><pub-id pub-id-type="pmid">26449265</pub-id>
</element-citation></ref><ref id="REF21"><label>21</label><element-citation publication-type="journal"><article-title>Variations of basal cell carcinomas according to gender, age, location and histopathological subtype</article-title><source>Br J Dermatol</source><person-group>
<name><surname>Scrivener</surname><given-names>Y</given-names></name>
<name><surname>Grosshans</surname><given-names>E</given-names></name>
<name><surname>Cribier</surname><given-names>B</given-names></name>
</person-group><fpage>41</fpage><lpage>47</lpage><volume>147</volume><year>2002</year><pub-id pub-id-type="pmid">12100183</pub-id>
</element-citation></ref><ref id="REF22"><label>22</label><element-citation publication-type="journal"><article-title>Immunoexpression of p53 and COX-2 in basal cell carcinoma</article-title><source>Rom J Morphol Embryol</source><person-group>
<name><surname>Enache</surname><given-names>AO</given-names></name>
<name><surname>Stepan</surname><given-names>AE</given-names></name>
<name><surname>Margaritescu</surname><given-names>C</given-names></name>
<etal/>
</person-group><fpage>1115</fpage><lpage>1120</lpage><volume>59</volume><year>2018</year><uri xlink:href="https://rjme.ro/archive/59/4/13/">https://rjme.ro/archive/59/4/13/</uri><pub-id pub-id-type="pmid">30845292</pub-id>
</element-citation></ref><ref id="REF23"><label>23</label><element-citation publication-type="journal"><article-title>Histologic mimics of basal cell carcinoma</article-title><source>Arch Pathol Lab Med</source><person-group>
<name><surname>Stanoszek</surname><given-names>LM</given-names></name>
<name><surname>Wang</surname><given-names>GY</given-names></name>
<name><surname>Harms</surname><given-names>PW</given-names></name>
</person-group><fpage>1490</fpage><lpage>1502</lpage><volume>141</volume><year>2017</year><pub-id pub-id-type="pmid">29072946</pub-id>
</element-citation></ref><ref id="REF24"><label>24</label><element-citation publication-type="journal"><article-title>Basal cell carcinoma-treatments for the commonest skin cancer</article-title><source>Dtsch Arztebl Int</source><person-group>
<name><surname>Berking</surname><given-names>C</given-names></name>
<name><surname>Hauschild</surname><given-names>A</given-names></name>
<name><surname>K&#x000f6;lbl</surname><given-names>O</given-names></name>
<name><surname>Mast</surname><given-names>G</given-names></name>
<name><surname>Gutzmer</surname><given-names>R</given-names></name>
</person-group><fpage>389</fpage><lpage>395</lpage><volume>111</volume><year>2014</year><pub-id pub-id-type="pmid">24980564</pub-id>
</element-citation></ref><ref id="REF25"><label>25</label><element-citation publication-type="journal"><article-title>Synchronous triple malignancies in an Indian Albino: a case report</article-title><source>Cureus</source><person-group>
<name><surname>Darlington</surname><given-names>D</given-names></name>
<name><surname>Puthanmadhom Narayanan</surname><given-names>S</given-names></name>
<name><surname>Anitha</surname><given-names>FS</given-names></name>
</person-group><fpage>0</fpage><volume>10</volume><year>2018</year></element-citation></ref><ref id="REF26"><label>26</label><element-citation publication-type="journal"><article-title>Epidemiological and pathological aspects of skin cancer in North East of Romania</article-title><source>Rev Med Chir Soc Med Nat Iasi</source><person-group>
<name><surname>Andrese</surname><given-names>E</given-names></name>
<name><surname>Solovastru</surname><given-names>LG</given-names></name>
<name><surname>Taranu</surname><given-names>T</given-names></name>
<name><surname>Iancu</surname><given-names>LS</given-names></name>
</person-group><fpage>457</fpage><lpage>462</lpage><volume>118</volume><year>2014</year><uri xlink:href="https://www.revmedchir.ro/index.php/revmedchir/article/view/719">https://www.revmedchir.ro/index.php/revmedchir/article/view/719</uri><pub-id pub-id-type="pmid">25076715</pub-id>
</element-citation></ref><ref id="REF27"><label>27</label><element-citation publication-type="journal"><article-title>Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline</article-title><source>Eur J Cancer</source><person-group>
<name><surname>Stratigos</surname><given-names>A</given-names></name>
<name><surname>Garbe</surname><given-names>C</given-names></name>
<name><surname>Lebbe</surname><given-names>C</given-names></name>
<etal/>
</person-group><fpage>1989</fpage><lpage>2007</lpage><volume>51</volume><year>2015</year><pub-id pub-id-type="pmid">26219687</pub-id>
</element-citation></ref></ref-list></back></article>